NCT03951896

Efficacy of Platelet Rich Plasma Injections in Patients With Adhesive Capsulitis of the Shoulder

Completed EARLY_PHASE1 Last updated 16 May 2019

What this trial tests

EARLY_PHASE1 trial testing PRP in Adhesive Capsulitis of Shoulder in 32 participants. Completed in 4 September 2015.

Timeline

3 May 2014

Primary endpoint
4 September 2015

4 September 2015

Quick facts

Lead sponsor	Ege University
Phase	EARLY_PHASE1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	32
Start date	3 May 2014
Primary completion	4 September 2015
Estimated completion	4 September 2015

Drugs / interventions tested

• PRP — full drug profile →
• Saline injection

Conditions studied

• Adhesive Capsulitis of Shoulder — all drugs for Adhesive Capsulitis of Shoulder →
• Adhesive Capsulitis — all drugs for Adhesive Capsulitis →
• Frozen Shoulder — all drugs for Frozen Shoulder →

Sponsor

Ege University

Who can join

Adults 18 to 70, any sex, with Adhesive Capsulitis of Shoulder or Adhesive Capsulitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was done to investigate whether platelet rich plasma(PRP) injections are effective in the management of adhesive capsulitis of the shoulder(AC).Patients were randomized to 2 groups, and one group took PRP injections for 3 times every two weeks, while the other group took saline injections in same frequency and volume. A standardized exercise programme was also applied to all patients.

Patients were then evaluated with Shoulder Pain and Disability Index(SPADI), Visual analogous scales for pain and disability, Ranges of Movements and use of analgesics in before, after and 3rd month of the therapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.